Aktaş Pepe, N. Et Al. 2023. Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide. FEBS , (Tours, France), 103.

Aktaş Pepe, N., Atalay, T. N., Acar, B., Şenol, H., & Şen, A., (2023). Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide . FEBS (pp.103). Tours, France

Aktaş Pepe, Nihan Et Al. "Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide," FEBS, Tours, France, 2023

Aktaş Pepe, Nihan A. Et Al. "Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide." FEBS , Tours, France, pp.103, 2023

Aktaş Pepe, N. Et Al. (2023) . "Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide." FEBS , Tours, France, p.103.

@conferencepaper{conferencepaper, author={Nihan Aktaş Pepe Et Al. }, title={Investigating the anti-inflammatory activities of the new hybrid compound 4-((1-(3- nitrobenzyl)-4,5-dihydro-1H-1,2,3-triazol-4-yl) methoxy)benzohydrazide}, congress name={FEBS}, city={Tours}, country={France}, year={2023}, pages={103} }